focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews Aberdeen Latin American Income Fund

19 Aug 2019 12:12

RNS Number : 5115J
Aberdeen Latin American Inc Fd Ltd
19 August 2019
 

 

London, UK, 19 August 2019

Edison issues review on Aberdeen Latin American Income Fund (ALAI)

Aberdeen Latin American Income Fund (ALAI) offers broad exposure to Latin America (both equities and government debt). It is managed by Aberdeen Standard Investments' (ASI's) well-resourced global emerging markets equities and emerging market debt teams. They are cautiously optimistic on the outlook for Latin America, believing the continued low interest-rate environment is supportive for corporate earnings growth and has the potential to stimulate investor demand for attractively valued assets in the region. ALAI has generated solid double-digit annualised NAV and share price total returns over the last three years, with particularly strong absolute and relative performance in the last 12 months. The fund offers an attractive 4.9% dividend yield.

 

ALAI's current 14.0% share price discount to cum-income NAV compares with the 12.2% to 14.1% range of average discounts over the last one, three and five years. The board has maintained the fund's dividend at 3.5p per share for the last three financial years (current yield of 4.9%). Gearing of up to 20% of NAV is permitted; net gearing was 11.3% at end-June 2019.

Click here to view the full report.

 

Subscribe to Edison's content to receive reports by email.

All reports published by Edison are free-to-access and available on the website.

 

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttruts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group- 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRALLFLLTIIALIA
Date   Source Headline
11th Apr 202212:19 pmRNSNet Asset Value(s)
8th Apr 202212:06 pmRNSNet Asset Value(s)
7th Apr 202212:37 pmRNSNet Asset Value(s)
7th Apr 202210:18 amRNSMonth End Net Asset Value(s)
6th Apr 202212:48 pmRNSNet Asset Value(s)
5th Apr 20221:00 pmRNSNet Asset Value(s)
4th Apr 20221:36 pmRNSGearing disclosure
4th Apr 202212:44 pmRNSNet Asset Value(s)
31st Mar 202212:20 pmRNSNet Asset Value(s)
30th Mar 202212:30 pmRNSNet Asset Value(s)
29th Mar 20221:08 pmRNSNet Asset Value(s)
28th Mar 20221:01 pmRNSGearing disclosure
28th Mar 202212:20 pmRNSNet Asset Value(s)
25th Mar 20225:45 pmRNSCompliance with Market Abuse Regualtion
25th Mar 202212:03 pmRNSNet Asset Value(s)
24th Mar 202212:31 pmRNSNet Asset Value(s)
23rd Mar 202212:30 pmRNSNet Asset Value(s)
22nd Mar 202212:13 pmRNSNet Asset Value(s)
21st Mar 20222:12 pmRNSGearing Disclosures
21st Mar 20221:01 pmRNSNet Asset Value(s)
18th Mar 202212:29 pmRNSNet Asset Value(s)
17th Mar 202212:45 pmRNSNet Asset Value(s)
16th Mar 20221:10 pmRNSNet Asset Value(s)
15th Mar 20221:25 pmRNSNet Asset Value(s)
14th Mar 20223:44 pmRNSPortfolio disclosure
14th Mar 20221:20 pmRNSGearing disclosure
14th Mar 20221:10 pmRNSNet Asset Value(s)
11th Mar 202212:49 pmRNSNet Asset Value(s)
10th Mar 202212:54 pmRNSNet Asset Value(s)
9th Mar 20221:32 pmRNSNet Asset Value(s)
8th Mar 20221:04 pmRNSNet Asset Value(s)
7th Mar 20225:12 pmRNSGearing disclosure
7th Mar 202212:53 pmRNSNet Asset Value(s)
7th Mar 202210:40 amRNSMonth End Net Asset Value(s)
4th Mar 20226:06 pmRNSNet Asset Value(s)
3rd Mar 202212:52 pmRNSNet Asset Value(s)
2nd Mar 20222:22 pmRNSNet Asset Value(s)
2nd Mar 20221:52 pmRNSQuarterly disclosure
1st Mar 20227:00 amRNSEdison issues review on abrdn Latin American
28th Feb 20223:57 pmRNSGearing disclosure
28th Feb 20221:01 pmRNSNet Asset Value(s)
25th Feb 202212:50 pmRNSNet Asset Value(s)
24th Feb 202212:39 pmRNSNet Asset Value(s)
23rd Feb 202212:58 pmRNSNet Asset Value(s)
22nd Feb 20221:03 pmRNSNet Asset Value(s)
21st Feb 20221:12 pmRNSGearing disclosure
21st Feb 202212:11 pmRNSNet Asset Value(s)
18th Feb 20223:47 pmRNSDirectorate Changes
18th Feb 202211:57 amRNSNet Asset Value(s)
17th Feb 202211:02 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.